4552 — JCR Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥97bn
- ¥103bn
- ¥34bn
- 70
- 49
- 37
- 51
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4,928 | 3,422 | 8,653 | 19,404 | 5,412 |
Depreciation | |||||
Non-Cash Items | 127 | 57 | 47 | -306 | -733 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2,492 | 16 | -252 | -11,754 | -12,175 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,906 | 4,929 | 10,340 | 9,289 | -5,499 |
Capital Expenditures | -895 | -4,838 | -7,527 | -11,333 | -8,560 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1,135 | 677 | 4,237 | 8,083 | -6,442 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 240 | -4,161 | -3,290 | -3,250 | -15,002 |
Financing Cash Flow Items | — | -2 | 1 | — | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -917 | 2,048 | 8,304 | -2,179 | 1,948 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3,241 | 2,836 | 15,332 | 4,472 | -17,454 |